| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |